Gill PS - Search Results

1

Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.

Bhatia S, Hirsch K, Sharma J, Oweida A, Griego A, Keysar S, Jimeno A, Raben D, Krasnoperov V, Gill PS, Pasquale EB, Wang XJ, Karam SD. Bhatia S, et al. Among authors: gill ps. Sci Rep. 2016 Dec 12;6:38792. doi: 10.1038/srep38792. Sci Rep. 2016. PMID: 27941840 Free PMC article.

2

EphB4 expression and biological significance in prostate cancer.

Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. Xia G, et al. Among authors: gill ps. Cancer Res. 2005 Jun 1;65(11):4623-32. doi: 10.1158/0008-5472.CAN-04-2667. Cancer Res. 2005. PMID: 15930280

3

Up-regulation of EphB4 in mesothelioma and its biological significance.

Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS. Xia G, et al. Among authors: gill ps. Clin Cancer Res. 2005 Jun 15;11(12):4305-15. doi: 10.1158/1078-0432.CCR-04-2109. Clin Cancer Res. 2005. PMID: 15958611

4

EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.

Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS. Masood R, et al. Among authors: gill ps. Int J Cancer. 2006 Sep 15;119(6):1236-48. doi: 10.1002/ijc.21926. Int J Cancer. 2006. PMID: 16615113 Free article.

5

Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. Kumar SR, et al. Among authors: gill ps. Am J Pathol. 2006 Jul;169(1):279-93. doi: 10.2353/ajpath.2006.050889. Am J Pathol. 2006. PMID: 16816380 Free PMC article.

6

Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.

Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. Krasnoperov V, et al. Among authors: gill ps. Am J Pathol. 2010 Apr;176(4):2029-38. doi: 10.2353/ajpath.2010.090755. Epub 2010 Feb 4. Am J Pathol. 2010. PMID: 20133814 Free PMC article.

7

Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.

Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Li D, et al. Among authors: gill ps. Mol Pharm. 2013 Jan 7;10(1):329-36. doi: 10.1021/mp300461b. Epub 2012 Dec 18. Mol Pharm. 2013. PMID: 23211050 Free PMC article.

8

EphB4 as a therapeutic target in mesothelioma.

Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V. Liu R, et al. Among authors: gill ps. BMC Cancer. 2013 May 30;13:269. doi: 10.1186/1471-2407-13-269. BMC Cancer. 2013. PMID: 23721559 Free PMC article.

9

The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.

Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. Li X, et al. Among authors: gill ps, gill is. PLoS One. 2014 Aug 22;9(8):e105326. doi: 10.1371/journal.pone.0105326. eCollection 2014. PLoS One. 2014. PMID: 25148033 Free PMC article.

10

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.

Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. Kumar SR, et al. Among authors: gill ps. Br J Cancer. 2007 Apr 10;96(7):1083-91. doi: 10.1038/sj.bjc.6603642. Epub 2007 Mar 13. Br J Cancer. 2007. PMID: 17353927 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page